Your browser doesn't support javascript.
loading
Patient-reported health-related quality of life from a randomized, placebo-controlled phase 2 trial of zuranolone in adults with major depressive disorder.
Suthoff, Ellison; Kosinski, Mark; Arnaud, Alix; Hodgkins, Paul; Gunduz-Bruce, Handan; Lasser, Robert; Silber, Christopher; Sankoh, Abdul J; Li, Haihong; Werneburg, Brian; Jonas, Jeffrey; Doherty, James; Kanes, Stephen J; Bonthapally, Vijayveer.
Afiliação
  • Suthoff E; Sage Therapeutics, Inc., Cambridge, MA, United States of America. Electronic address: ellison.suthoff@sagerx.com.
  • Kosinski M; Optum, Johnston, RI, United States of America.
  • Arnaud A; Sage Therapeutics, Inc., Cambridge, MA, United States of America.
  • Hodgkins P; Sage Therapeutics, Inc., Cambridge, MA, United States of America.
  • Gunduz-Bruce H; Sage Therapeutics, Inc., Cambridge, MA, United States of America.
  • Lasser R; Sage Therapeutics, Inc., Cambridge, MA, United States of America.
  • Silber C; Sage Therapeutics, Inc., Cambridge, MA, United States of America.
  • Sankoh AJ; Sage Therapeutics, Inc., Cambridge, MA, United States of America.
  • Li H; Sage Therapeutics, Inc., Cambridge, MA, United States of America.
  • Werneburg B; Sage Therapeutics, Inc., Cambridge, MA, United States of America.
  • Jonas J; Sage Therapeutics, Inc., Cambridge, MA, United States of America.
  • Doherty J; Sage Therapeutics, Inc., Cambridge, MA, United States of America.
  • Kanes SJ; Sage Therapeutics, Inc., Cambridge, MA, United States of America.
  • Bonthapally V; Sage Therapeutics, Inc., Cambridge, MA, United States of America.
J Affect Disord ; 308: 19-26, 2022 07 01.
Article em En | MEDLINE | ID: mdl-35378149

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Humans Idioma: En Revista: J Affect Disord Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Transtorno Depressivo Maior Tipo de estudo: Clinical_trials / Prognostic_studies Limite: Adult / Humans Idioma: En Revista: J Affect Disord Ano de publicação: 2022 Tipo de documento: Article